EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

Indian Pharma Exports Rise 6.6%: Nifty Pharma Hits Record High in 2026 - India’s pharmaceutical sector has entered the second half of 2026 on a strong footing, with exports rising 6.6% year-on-year and the Nifty Pharma index hitting an all-time high in early July. Despite global headwinds including geopolitical tensions in West Asia and shifting US trade policies, Indian pharma companies continue to demonstrate resilience and growth momentum, […]
India Pharma Mid-2026: FDA Filings Lead China, API Prices Drop, Biosimilars Rise - India’s pharmaceutical sector continues to strengthen its global position with a series of positive developments in mid-2026. From extending its lead over China in US FDA drug master filings to falling API prices that boost manufacturer margins, and an accelerating push into biosimilars, Indian pharma is navigating a dynamic landscape with strategic confidence. This roundup […]
US-India Trade Deal Very Close: Indian Generics Sector Gains Edge - The long-anticipated US-India bilateral trade deal is moving toward finalization, with major implications for India’s generic pharmaceutical industry. US President Donald Trump confirmed at the G7 summit in Évian, France on June 18, 2026, that the agreement is “very close,” while US and Indian trade negotiators continue to refine the remaining provisions covering tariffs, intellectual […]
India Pharma 2026: CDSCO Fast-Track Trials, Biosimilar Guidelines, and Innovation Agenda - The Indian pharmaceutical sector is undergoing a significant transformation in 2026, driven by landmark regulatory reforms from the Central Drugs Standard Control Organization (CDSCO), new clinical trial fast-track rules, updated biosimilar guidelines, and a government-wide push for innovation-led growth. Health Minister J P Nadda recently affirmed that India is “well-positioned in the pharma industry” amid […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us